When Saving Lives Meant Letting Others Die: Helsinki's Moral Rift
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
A single phrase in an eleven-paragraph document shifted consent from "absolutely" to "to the fullest extent possible," letting proxy consent and placebo trials move from rare exceptions into global practice - and by the late 1990s geography alone was deciding who received life-saving treatments. How did a declaration with no legal teeth end up governing experiments that let some women receive a drug that cut mother-to-child HIV transmission by nearly 70% while others got placebo?
In this episode, we lay out the decisions, clauses, and institutional choices that connected Nuremberg to Helsinki to AIDS trials in the 1990s, and ask whether professional consensus can ethically substitute for law when lives are at stake.
Person: Twenty-three German physicians
Date: June 1964
Document: Declaration of Helsinki (eleven paragraphs)
Study: AIDS Clinical Trials Group Study 076 (Zidovudine)
Result: nearly 70% reduction in mother-to-child HIV transmission
- Nuremberg Tribunal produced the Nuremberg Code with ten principles in 1947.
- Helsinki replaced the Nuremberg Code's "absolutely essential" consent with "to the fullest extent possible" in June 1964.
- The 1975 Tokyo revision of Helsinki introduced independent protocol-review committees and prioritized subjects' interests over science.
- The 1994 Zidovudine trial (Study 076) showed nearly 70% reduction in maternal HIV transmission.
- The FDA adopted the 1996 version of Helsinki, allowing placebo where "no proven method existed," while ignoring later revisions.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません